
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About


SINTX Technologies Inc (SINT)


- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)

(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: SINT (1-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $25
1 Year Target Price $25
1 | Strong Buy |
0 | Buy |
1 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -26.72% | Avg. Invested days 17 | Today’s Advisory WEAK BUY |
Upturn Star Rating ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() | ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 14.59M USD | Price to earnings Ratio - | 1Y Target Price 25 |
Price to earnings Ratio - | 1Y Target Price 25 | ||
Volume (30-day avg) 2 | Beta 0.83 | 52 Weeks Range 1.71 - 8.60 | Updated Date 10/17/2025 |
52 Weeks Range 1.71 - 8.60 | Updated Date 10/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -8.4 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -1733.11% |
Management Effectiveness
Return on Assets (TTM) -37.72% | Return on Equity (TTM) -195.48% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 10547935 | Price to Sales(TTM) 7.84 |
Enterprise Value 10547935 | Price to Sales(TTM) 7.84 | ||
Enterprise Value to Revenue 11.1 | Enterprise Value to EBITDA -0.56 | Shares Outstanding 2758865 | Shares Floating 2207340 |
Shares Outstanding 2758865 | Shares Floating 2207340 | ||
Percent Insiders 14.72 | Percent Institutions 4.77 |
Upturn AI SWOT
SINTX Technologies Inc

Company Overview
History and Background
SINTX Technologies, Inc. (formerly Ceramatec, Inc.) was founded in 1996. It focuses on developing and commercializing silicon nitride for various applications, particularly in biomedical and industrial sectors. The company has evolved from a research-oriented organization to one focused on commercialization and strategic partnerships.
Core Business Areas
- Biomedical: Developing and manufacturing silicon nitride-based products for orthopedic implants, dental implants, and other biomedical applications. This segment focuses on leveraging silicon nitride's biocompatibility and osteoconductive properties.
- Industrial: Applying silicon nitride technology to industrial applications, such as wear-resistant components, cutting tools, and other high-performance materials. This segment focuses on silicon nitride's hardness and durability.
Leadership and Structure
SINTX Technologies is led by an executive team with expertise in materials science, engineering, and business development. The organizational structure includes departments for research and development, manufacturing, sales and marketing, and finance.
Top Products and Market Share
Key Offerings
- Silicon Nitride Powder: SINTX manufactures and sells silicon nitride powder for various applications. Market share data is not publicly available in precise figures. Competitors include Ube Industries, Denka, and Kyocera.
- Orthopedic Implants: SINTX develops silicon nitride orthopedic implants. Market share data is not publicly available in precise figures. Competitors include Stryker, Johnson & Johnson (DePuy Synthes), and Zimmer Biomet.
Market Dynamics
Industry Overview
The market for advanced ceramics, including silicon nitride, is growing due to increasing demand from biomedical, automotive, and industrial sectors. Factors driving growth include the need for high-performance materials with superior strength, wear resistance, and biocompatibility.
Positioning
SINTX Technologies positions itself as a leader in silicon nitride technology, particularly in biomedical applications. Its competitive advantages include its expertise in silicon nitride processing and its focus on biocompatible materials.
Total Addressable Market (TAM)
The global advanced ceramics market is estimated to be worth billions of dollars. SINTX is positioned to capture a share of this market through its silicon nitride technology, focusing on high-growth biomedical applications such as spinal and orthopedic implants.
Upturn SWOT Analysis
Strengths
- Proprietary silicon nitride technology
- Strong IP portfolio
- Focus on high-growth biomedical applications
- Experienced management team
Weaknesses
- Limited financial resources
- Reliance on strategic partnerships
- Small market capitalization
- History of losses
Opportunities
- Expanding into new biomedical applications
- Securing additional strategic partnerships
- Increasing demand for advanced ceramics
- Government funding for materials science research
Threats
- Competition from larger materials science companies
- Technological obsolescence
- Economic downturns
- Regulatory hurdles
Competitors and Market Share
Key Competitors
- UBEOY
- OTCPK:DECPF
- KYOCY
Competitive Landscape
SINTX's competitive advantage is its focus on silicon nitride technology and biomedical applications. However, it faces challenges from larger, more established companies with greater financial resources.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been variable, with periods of rapid growth followed by declines.
Future Projections: Future growth is dependent on securing additional strategic partnerships and commercializing new products. Analyst estimates vary widely.
Recent Initiatives: Recent initiatives include expanding sales and marketing efforts, developing new silicon nitride products, and strengthening its IP portfolio.
Summary
SINTX Technologies shows promise with its silicon nitride technology and focus on biomedical applications, leveraging its intellectual property to carve out a niche. Financial stability and resource constraints pose ongoing challenges. Future success hinges on strategic partnerships, product commercialization, and navigating a competitive landscape. Monitoring financial performance and maintaining focus are crucial for realizing its potential.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC Filings (10-K, 10-Q), Company Press Releases, Investor Presentations, Industry Reports
Disclaimers:
This analysis is based on publicly available information and should not be considered investment advice. Market share data is estimated and may not be precise. Financial data is for illustration only and should be verified through official filings.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About SINTX Technologies Inc
Exchange NASDAQ | Headquaters Salt Lake City, UT, United States | ||
IPO Launch date 2014-02-13 | President, CEO & Chairman of the Board Mr. Eric K. Olson | ||
Sector Healthcare | Industry Medical Devices | Full time employees 20 | Website https://www.sintx.com |
Full time employees 20 | Website https://www.sintx.com |
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.